Chief Technology Officer, Co-founder, PhD, Associate Professor Karolinska Institutet
Research and development
CTO and co-founder of Stratipath.
+15 years experience from predictive modelling and large-scale data analysis (ML, AI, statistics) in the academic medical/lifescience area. Currently leading multiple national and international research consortia focused on AI-based precision pathology. Associate professor (docent) at the Department of Medical Epidemiology and Biostatistics at Karolinska Insitutet. PhD from Imperial College London (2004-2008), Research Fellow at University of Oxford 2008-2013 (Department of Statistics & Wellcome trust center for human genetics).
Stratipath brings together physicians, researchers, AI-scientists, developers and industry specialists with its aim to help all patients get the right treatment through precision diagnostics. Stratipath is a spin-out from Karolinska Institutet in Stockholm, Sweden, bringing pioneering research from the fields of AI and precision medicine into clinical use. The company was founded in 2019 with a mission to radically improve cancer treatment decisions and patient outcomes. Stratipath uses AI technology and research to improve cancer diagnostics for more patients. Today far too many patients receive inconclusive cancer diagnoses and have unequal access to precision diagnostics. Stratipath’s AI technology can change this by providing patients with faster access to novel, more conclusive and precise results, at a sustainable cost.
Already working at Stratipath AB?
Let’s recruit together and find your next colleague.